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ABSTRACT
RNA interference is mediated by small interfering
RNAs (siRNAs) that upon incorporation intothe RNA-
induced silencing complex (RISC) can target
complementary mRNA for degradation. Standard
siRNA design usually feature a 19–27 base pair
contiguous double-stranded region that is believed
to be important for RISC incorporation. Here, we
describeanovelsiRNAdesigncomposedofanintact
antisense strand complemented with two shorter
10–12nt sense strands. This three-stranded con-
struct, termed small internally segmented interfering
RNA (sisiRNA), is highly functional demonstrating
that an intact sense strand is not a prerequisite for
RNA interference. Moreover, when using the sisiRNA
design only the antisense strand is functional in
activated RISC thereby completely eliminating unin-
tended mRNA targeting by the sense strand.
Interestingly, the sisiRNA design supports the func-
tion of chemically modified antisense strands, which
are non-functional within the context of standard
siRNA designs. This suggests that the sisiRNA
design has a clear potential of improving the
pharmacokinetic properties of siRNA in vivo.
INTRODUCTION
RNA interference (RNAi) was initially discovered in
Caenorhabditis elegans by Fire and colleagues, who
showed that introduction of long double-stranded RNA
(dsRNA) caused a nearly complete inhibition of genes
harboring the same sequence (1). It was subsequently
demonstrated that short  21bp dsRNAs, termed small
interfering RNA (siRNA), were functional triggers of
RNAi without inducing the innate immune responses
associated with longer dsRNA in mammalian cells (2).
Natural siRNAs are processed from longer dsRNA species
derived from, e.g. virus, mobile elements or transgenic
RNA by the cytoplasmic RNAse III enzyme Dicer (3).
Similarly, exogenous 19–27bp siRNAs are functional if
introduced into the cytoplasm (2). Here, the siRNA will be
incorporated into the RNA-induced silencing complex
(RISC) by a RISC loading complex (RLC), which is best
described in Drosophila (4), but likely also exists in humans
(5). By sensing the thermodynamic asymmetry of siRNA
duplex ends, RLC distinguishes the siRNA guiding
antisense strand from the sense strand, thereby dictating
the so-called pre-RISC to assemble asymmetrically on the
siRNA duplex (4,6). Although both strands of the siRNA
duplex are initially incorporated into pre-RISC, the RLC-
tagged sense strand is subsequently cleaved and released
thereby establishing activated RISC which contains only
the single stranded antisense strand. Recent data suggest
that the catalytic core protein of RISC, the Ago2
endonuclease, initiates sense strand elimination by cleaving
it 9nt from its 50 end during RISC activation (7–9).
Although the helicase activity for unwinding the duplex
remains unidentiﬁed, these events expose the antisense
strand in RISC to the mRNA target, which is subsequently
cleaved probably by a similar mechanism.
The use of synthetic siRNAs in vivo is currently
hampered by lack of eﬃcient means of siRNA delivery,
low biostability in biological ﬂuids and low speciﬁcity of
action due to inherent gene oﬀ-target eﬀects caused by the
microRNA-like behavior of all investigated siRNAs
(10–12). Several attempts to reduce oﬀ-target eﬀects
through chemical modiﬁcation of synthetic siRNA have
been made (13,14). Since both strands of a siRNA duplex
can contribute to oﬀ-target eﬀects (10), minimizing sense
strand incorporation into activated RISC should
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established that the siRNA strand with the thermodyna-
mically least stable 50 end is preferentially utilized as
antisense strand in activated RISC (6,15). Accordingly,
selective thermodynamic stabilization of sense strand 50
ends by incorporation of locked nucleic acids (LNA) has
been shown to reduce unwarranted gene silencing by the
sense strand (13,16). Here, we apply a radically diﬀerent
design characterized by an intact antisense strand com-
plemented with two shorter 9–13nt sense strands, together
named small internally segmented interfering RNA
(sisiRNA, Table 1). We show that only the antisense
strand of this construct is capable of gene silencing thereby
signiﬁcantly increasing targeting speciﬁcity. Moreover,
incorporation of LNA nucleotides into the disrupted sense
strand signiﬁcantly increases serum stability which may be
important for in vivo applications. Interestingly, the
sisiRNA design can functionally accommodate heavily
modiﬁed antisense strands that are non-functional as
standard siRNAs. This potentially allows the application
of more highly functionalized siRNA designs.
MATERIALS AND METHODS
Constructs and cells
The human lung cancer cell line H1299 produced to stably
express EGFP (EGFP half-life 2h) was a gift from
Dr Anne Chauchereau (CNRS, Villejuif, France). H1299
and T98G cells were grown in RPMI-1640 containing
10% FBS, 1% penicillin/streptomycin.
The two reporter constructs pISOantisense-target and
pISOsense-target were constructed by annealing equimolar
amounts of the following DNA oligoes 50-GCGACG
TAAACGGCCACAAGTTC-30 and 30-TCGACGCTGC
ATTTGCCGGTGTTCAAGGATC-5 (antisense target)
or 50-CTAGGCGACGTAAACGGCCACAAGTTCA
GCT-30 and 30-CGCTGCATTTGCCGGTGTTCAAG-50
(sense target) into SacI/NheI digested pISO (kindly
provided by David Bartel) (17) downstream of the ﬁreﬂy
luciferase coding sequence.
siRNA synthesis
Non-modiﬁed and LNA-modiﬁed RNA oligoes were
prepared on an automated DNA synthesizer as
described earlier (16). The synthesis of adamantyl and
pyrenyl containing RNA oligoes is described elsewhere
(J.W., S.W.L., B.R.B., manuscript in preparation).
Sense and antisense strands where mixed in annealing
buﬀer (10mM Tris–HCl, pH 7.3, 50mM NaCl) at 20mM
equimolar concentration and incubated at 958C for 1min
and at 1h at 378C.
Quantification of EGFP and GAPDH
Cells used for EGFP northern, western andﬂow-cytometry
analysis were seeded at  20% conﬂuency and transfected
using Bio-Rad Silentfect transfection reagent (50 nM ﬁnal
RNA concentration) according to manufacturer’s instruc-
tions. Twenty-four hours later cells were replenished with
fresh medium and incubated for another 24h before either
re-transfection using Lipofectamine2000 (50 nM ﬁnal
RNA concentration) according to manufactures directions
or harvested for western blot analysis, northern blot
analysis or ﬂow-cytometry analysis (counting approxi-
mately 5 10
4 cells and averaged). Western blotting was
performed as follows: cells were washed twice in PBS and
an equal amount of cells were lysed in 2  SDS sample
buﬀer [4% Sodium Dodecyl-Sulphate (SDS), 20% glyc-
erol, 125mM Tris/HCl pH 6.8, 0.01mg/ml Bromphenol
Blue, 10% b-mercaptoethanol] at 908C for 2 10min
separated by gentle pippeting. Proteins were separated in
12% SDS acrylamide gels and electroblotted overnight
onto a PVDF membrane (Immobilon). The ﬁlter was
blocked for 1h with PBS containing 10% w/v milk. EGFP
protein was detected using a 1:1000 dilution of a rabbit
polyclonal EGFP antibody. The mouse hnRNP C1 anti-
body was a gift from Seraphin Pinol-Roma. A horseradish
peroxidase (hrp) conjugated secondary antibody (DAKO)
was used with ECL reagent (Amersham Biosciences) for
visualization. EGFP mRNA was analyzed by northern
blotting according to standard procedures.
GAPDH mRNA expression was quantiﬁed by northern
blotting; wild-type H1299 cells were transfected at 50%
conﬂuency using TransIT-TKO transfection reagent
(Mirus) according to the manufactures protocol (10 nM
ﬁnal RNA concentration). RNA was harvested 48h post-
transfection using TRIzol reagent (Invitrogen) and
northern blotting was performed according to standard
procedures.
Interferonresponse assay
siRNA-variants (80 nM) or poly(I:C) (0.8mg/ml) were
transfected into T98G cells using the TransIT-TKO
transfection reagent (Mirus) according to the manufac-
tures protocol. Total RNA was puriﬁed using Trizol
reagent (Invitrogen), DNase treated and subjected to
oligo-dT-primed reverse transcription. qPCR was per-
formed using the platinum SYBRGreen qPCR supermix
(Invitrogen) on a Stratagene Mx3005p qPCR system.
Primers used for ampliﬁcation of ISG56: 50-AAGG
CAGGCTGTCCGCTTA-30 and 50-TCCTGTCCTTCAT
CCTGAAGCT-30. Primers for amplifying GAPDH:
50-GAAGGTGAAGGTCGGAGT-30 and 50-GAAGAT
GGTGATGGGATTTC-30. The PCR conditions are:
1 cycle: 958C 10min, 40 cycles: 958C3 0 s ,5 5 8C 1min,
728C 30s, 1 cycle: 958C3 0 s ,5 5 8C 1min, 958C 1min.
Relative quantiﬁcation of mRNAs levels were done by
using the iiCT-method. The experiments were done in
triplicates and ISG56 levels for siRNA-treated cells were
normalized to TransIT-TKO treated controls.
siRNA stability assay
Annealed LNA-modiﬁed sisiRNAs, LNA-modiﬁed
siRNAs or siRNAs were incubated at 378C in either
10% or 80% fetal calf serum in DMEM (Gibco). Aliquots
of 5ml (each containing 20 pmol of siRNA) were diluted in
25ml 1.2  TBE loading buﬀer (1.2  TBE, 10% glycerol,
bromphenol blue) and snap-frozen on dry ice immediately
upon sample taking. Samples were run on a 15% native
polyacrylamide gel and stained using SYBR Gold
(Invitrogen).
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RNA Oligoes
Oligonucleotide sequences and chemical modiﬁcations. Top panel. List of RNA oligoes used in this study. SS and AS denote sense strand and
antisense strand, respectively. SS1 corresponds to a continuous version of 50SS1 and 30SS1. 50SS3/ 30SS3 and 50SS4/ 30SS4 are variants of the 50SS1
and 30SS1 pair where the nick has been shifted one position towards the 30 end and 50 end, respectively. 50SS2 and 30SS2 are the RNA versions of
50SS1 and 30SS1. 30SS4 is equivalent to 30SS1 but without a 30 terminal U-residue. Bold underlined letters indicate the position of the LNA
nucleotides. C: LNA-5-Me cytosine, G: LNA-Guanine, T: LNA-Thymine, aT:N 2 0-adamantylmethylcarbonyl 20-amino-LNA-thymine, pT:
N20-pyren-1-ylmethyl 20-amino-LNA-thymine. Bottom panel: Selected examples of duplexes used in this study. Sense strand is at the top.
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H1299 cells were plated in 6-well plates in RPMI
supplemented with 10% fetal bovine serum and grown
ON to 40–60% conﬂuency. pISOantisense-target and
pISOsense-target (1mg) were co-transfected with 0.002mg
pRluc-N2 (Perkin–Elmer) and the siRNA duplexes
(10 nM ﬁnal concentration) by simultaneous use of 6ml
TransIT-LT1 (Mirus) and 6ml TransIT-TKO (Mirus)
according to the manufactures protocol. The Dual-
luciferase assay was done 48h posttransfection using the
‘Dual-luciferase reporter assay system’ (Promega) accord-
ing to the manufactures protocol. The luciferase activities
were measured on a Lumat LB 950 luminometer
(Berthold) and normalized to the renilla luciferase signal.
RESULTS
AsiRNA containing anicked sense strand isfully functional
To eliminate sense strand incorporation into activated
RISC, we applied a novel siRNAs design characterized by
an intact antisense strand complemented with two shorter
sense strands. We anticipated that by incorporating LNA
nucleotides into such tri-molecule construct, suﬃcient
stability and dsRNA structural mimicry would be
achieved to allow RNA interference activity. We initially
designed a sisiRNA composed of a 10 and 12nt sense
strand directed towards a previously established func-
tional target in the mRNA encoding enhanced green
ﬂuorescent protein (EGFP)(18). To stabilize the sisiRNA
construct we incorporated LNA at two and four positions
in the sense 50 and 30 half-strands, respectively, and near
the 30 end of the antisense strand and assembled the
construct from these three strands [AS1+50SS1+30SS1
(sisiRNA), Table 1]. Together with a standard siRNA and
unrelated control siRNA, the constructs were tested by
transfection into an H1299 lung carcinoma cell line that
stably expresses destabilized EGFP. Subsequently, the
level of EGFP mRNA and protein expression was
monitored on the basis of ﬂuorescence microscopy
(Figure 1A), northern blotting (Figure 1B), western
blotting (Figure 1C) and ﬂow cytometry (Figure 1D).
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Figure 1. Testing the knock down of EGFP by sisiRNA and related constructs. The EGFP expression was assessed both at the RNA and protein
level in H1299 cells. (A) Fluorescence microscopy analysis of EGFP expression in H1299 cells. Cells were treated with 50nM of the indicated
combinations of RNA/LNA oligoes and analyzed 48hours after for EGFP expression. (B) Northern blot showing EGFP mRNA expression 48
and 120hours after initial transfection with 50nM of the indicated combinations of oligonucleotides. (C) Western blot showing the expression
of EGFP protein in cells at 48, 120 and 180 hours after transfection with 50nM of the indicated RNA constructs. The ﬁlter was reprobed with
an antibody speciﬁc to hnRNPC1 protein as a loading control. (D) Flow cytometry analysis showing the mean green ﬂuorescence of 50.000 cells
48hours posttransfection (based on three experiments).
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siRNA yielded a comparable 10-fold knock down after
48h (Figure 1B–D). The duration of the knock down eﬀect
by the sisiRNA was similar or slightly superior to unmodi-
ﬁed siRNA at 120 (5 days) or 180h (7.5 days) (Figure 1B
and C). Hence, sisiRNA exhibits similar silencing activity
in cell culture as compared to standard siRNAs. The
activity of the LNA-modiﬁed sisiRNA was strictly
depending on the presence of all three strands as omitting
one or both of the short sense strands (50SS1 or 30SS1)
eliminated the activity of the sisiRNA (Figure 1A–C).
To investigate if the sisiRNA design is applicable to
other target sequences, we additionally targeted the
endogenous gene GAPDH in H1299 cells using two
sisiRNA designs diﬀering only in the position of the LNA
residues in passenger fragments [AS8+50SS6+30SS6
(siGAPDH 1) and AS8+50SS6 +30SS6  (siGAPDH 2),
Table 1] and compared them to unmodiﬁed siRNA
targeting GAPDH [AS7+SS7 (siGAPDH), Table 1] and
LNA-modiﬁed siRNA [AS8+SS6 (siGAPDH, LNA),
Table 1]. All four constructs resulted in a similar  60%
reduction in GAPDH mRNA levels (Figure 2A and B,
columns 1–4) as compared to cells transfected with EGFP-
speciﬁc siRNA or non-transfected controls (Figure 2A
and B, columns 5 and 6). Competitive knock down levels
have also been observed with sisiRNA directed towards
H-Ras in HeLa cells (M.B.L. unpublished data). Hence,
the sisiRNA design has proven highly functional for all
tested targets with eﬃciencies similar to unmodiﬁed or
LNA-modiﬁed siRNA.
LNA modifications are essential forthesisiRNA design,
increases sisiRNA serum stability and arenon-immunogenic
incell culture
We speculated that the LNA-modiﬁed siLNA and
sisiRNA designs may have greater stability compared to
unmodiﬁed siRNAs, both in terms of premature strand
separation and resistance to RNases. In accordance, we
found that upon incubation in 80% FCS, unmodiﬁed
siRNAs were rapidly degraded within 1½ h whereas a
large proportion of both LNA-modiﬁed sisiRNA and an
identical construct, but with continuous sense strand
(AS1+SS1, Table 1), remained intact for 780min (13h)
(Figure 3A). Notably, we have observed no signiﬁcant
knock down when using a sisiRNA containing only
unmodiﬁed residues (data not shown) suggesting that
LNA modiﬁcations are not only beneﬁcial but also
essential for the integrity of the sisiRNA design in
biological ﬂuids. This is compatible with the observation
that LNA-modiﬁcations in the complementary part of
either the antisense or sense strand are essential for
sisiRNA serum stability (Figure 3B). Hence, we conclude
that the sisiRNA design is highly stable in serum despite of
the introduction of an internal nick in the sense strand.
Chemical modiﬁcations of nucleic acids can have a
dramatic inﬂuence on the cellular immune response in
cultured cells and in animals (19,20). We did, however, not
observe any cytotoxic side-eﬀects or growth inhibition in
sisiRNA-treated cells as compared to standard siRNAs
(data not shown). To analyze that the sisiRNA design
does not trigger cellular interferon responses, we trans-
fected the human glioblastoma T98G cell line using 80 nM
of the diﬀerent siRNA constructs and measured the
induction of ISG56, which is strongly induced by both
types of IFNs (21) and dsRNA (22). ISG56 induction has
previously been reported in T98G cells upon siRNA
transfection (23), yet no signiﬁcant diﬀerences in ISG56
induction were observed between LNA-modiﬁed sisiRNA,
LNA-modiﬁed siRNA and unmodiﬁed siRNA
(Figure 3C). In contrast, poly(I:C) induced the ISG56
several hundred fold. Hence, at least in cell culture,
sisiRNA appears to be immunologically similar to
standard siRNAs.
Position and size of thesisiRNA sense strand nick
To further optimize the sisiRNA design, we tested a
series of diﬀerent sense and antisense strands. In one
experiment, the position of the gap in the sense strand
was either shifted one position towards the 30 end
[AS1+50SS3+30SS3 (sisiRNA11+11), Table 1] or one
position towards the 50 end [AS1+50SS4+30SS4
(sisiRNA9+13), Table 1] which since the initiation of this
work has been reported to be the natural cleavage site for
Ago2 in RISC (7–9). For the sisiRNA11+11 design, only a
minor decline in silencing was observed whereas the
sisiRNA9+13 design was slightly less eﬃcient in gene
silencing (Figure 4A, compare columns 1–3). A similar
minor decline in knock down eﬃciency was seen for a
sisiGAPDH9+13 design as compared to siGAPDH 1 and
siGAPDH 2 (data not shown). These data underscore the
notion that the position of LNA modiﬁcations need not be
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Figure 2. Knockdown of GAPDH mRNA by sisiRNA. (A) Northen
blot analysis of GAPDH mRNA expression in H1299 cells 48h after
transfection of either siGAPDH, siGAPDH (LNA), sisiGAPDH 1,
siGAPDH 2 or siEGFP as indicated. Upper panel: GAPDH mRNA as
evaluated by northern blotting using a GAPDH probe. Lower panel:
ethidium bromide staining of 18S rRNA (loading control). Experiments
were performed in triplicates. (B) Quantiﬁcation of GAPDH mRNA
levels in (A). All values are normalized to siEGFP transfected cells.
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Figure 3. Serum stability of the sisiRNA design. (A) LNA-modiﬁed sisiRNA and LNA-modiﬁed siRNA have increased serum stability compared to
unmodiﬁed siRNA. The siRNA variants were incubated in 80% FCS and aliquots taken at indicated time points. Serum-stability was evaluated by
PAGE followed by SYBR Gold staining. Whereas siRNA is degraded within 1–1½ h of serum incubation, signiﬁcant amount of LNA-modiﬁed
sisiRNA and LNA-modiﬁed siRNA are still present after 13h of incubation. A size marker is indicated to the left. (B) LNA-base pairing is essential
for the integrity of sisiRNA molecules upon incubation in 10% FCS. The indicated sisiRNA molecules carrying diﬀerent or no LNA modiﬁcations
were incubated in the presence (+) or absence ( ) of 10% FCS for 24h and duplex stability was evaluated by PAGE followed by SYBR Gold
staining. sisiRNA constructs with LNA in both strands exhibited full stability whereas sisiRNA containing only RNA were completely degraded
upon serum incubation. The position of the LNA modiﬁcations are indicated schematically (vertical lines). (C) LNA-modiﬁed sisiRNA and LNA-
modiﬁed siRNA do not activate the interferon system as evaluated by induction of ISG56 in T98G cells. The glioblastoma cell line T98G was
transfected with 80 nM of the siRNA variants or 0.8 mg poly(I:C) as indicated and ISG56 mRNA levels evaluated by qPCR analysis 48h
posttransfection. Only transfection of poly(I:C) (pos. control) lead to high levels of ISG56 induction, whereas ISG56 levels for all siRNA-variants
were indistinguishable from untreated cells or cells treated with transfection reagent alone (Mirus Trans-IT TKO).
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Figure 4. Optimization the sisiRNA design. The knock down eﬃciencies between diﬀerent sisiRNA and siRNA designs were compared by targeting
EGFP mRNA. (A) Analyzing the eﬀect of diﬀerent gap positions in the sense strand. The numbers correspond to the size of the 50 and 30 fragment of
the sense strand, respectively. (B) Analyzing the eﬀect of modiﬁcations at the 30 terminal nucleotide on the sense strand. The mean ﬂuorescence of
approximately 50 000 cells was measured by ﬂow cytometry. The siRNA mismatch represents a siRNA that contains four mismatches to the EGFP
target (Table 1).
5892 Nucleic Acids Research, 2007, Vol. 35, No. 17ﬁxed within the sisiRNA (Figure 2A and B) and the
position of the nick in the passenger strand need not to
mimic the natural cleavage site (Figure 4A). Increasing the
gap size of the sense strand of the sisiRNA duplex to
1–2nt resulted in a dramatic decline in sisiRNA activity
irrespectively of gap position (data not shown).
In conclusion we ﬁnd ﬂexibility in positioning of both
the LNA modiﬁcations and the sense strand central nick,
yet the sisRNA10+12 design has proven most eﬃcient
among the sisiRNAs combinations tested (Figure 4A, data
not shown).
The 30SS1 strand was initially designed to contain an
additional U-residue at the 30 end in order to ease the
chemical synthesis. To test whether this residue aﬀects
sisiRNA activity, 30SS1 was synthesized without this
terminal U-residue (30SS5; Table 1). This alteration did
not alter the activity of the construct signiﬁcantly
(compare columns 2 and 4, Figure 4B).
The discontinuity of thesense strand completely eliminates
its guide activity
To test whether the discontinuity of the intended sense
strand eliminates its contribution to gene silencing we
inserted the EGFP target sequence for either the
siRNAEGFP antisense or sense strand within the 30 UTR
of a ﬁreﬂy luciferase reporter construct (Figure 5). This
strategy allowed us to diﬀerentially assess the knock down
eﬀect derived from the antisense and the sense strand
incorporation into activated RISC. As predicted, the
LNA-modiﬁed sisiRNA construct was signiﬁcantly more
speciﬁc than the equivalent siRNA and LNA-modiﬁed
siRNA duplexes since  50% knockdown was constantly
seen from the sense strand with standard siRNA design
(columns 2 and 4, Figure 5). In contrast, the sisiRNA
design completely abrogated the silencing of the ‘sense
target’ as compared to mismatch controls without
compromising the potent knockdown mediated by the
antisense strand (columns 5 and 6, Figure 5). To test
whether it is possible to abrogate the silencing function of
an otherwise optimal antisense strand with a nick, another
LNA-modiﬁed sisiRNA with an intact sense strand and a
discontinuous antisense strand (50AS2, 30AS2, SS3) was
tested for the ability to knock down the antisense and
sense targets (Table 1). This design completely eliminated
silencing of the antisense target yet retained silencing of
the sense target to a level comparable to the standard
siRNA (columns 7 and 8, Figure 5). Collectively these
data clearly demonstrate that the sisiRNA construct
exhibits a much higher level of speciﬁcity for the intended
target compared to the usual siRNA design.
The sisiRNA designis compatible withhigher levels
ofantisense modification
We and others have previously found that extensive LNA-
modiﬁcation of antisense strands strongly interfere with
RNAi activity in standard siRNA designs (Figure 6B,
column 2 and data not shown) (13,24). Therefore, we
initially designed AS1 to contain only two LNA residues
near the 30 end. To investigate whether the discontinuity of
the sense strand inﬂuences the requirement for unmodiﬁed
residues in the body of the antisense strand, we tested an
LNA-modiﬁed sisiRNA with a highly modiﬁed antisense
strand containing six LNA residues (AS2). This antisense
strand is essentially inactive when paired with an all-RNA
sense strand (data not shown) or an LNA-modiﬁed sense
strand (LNA-modiﬁed siRNA duplex AS2+SS1, Table 1;
Figure 6B, column 2). Interestingly, the requirement for
unmodiﬁed residues in the antisense strand was less
stringent when using the sisiRNA design (compare
columns 2 and 3, Figure 6B). A similar improvement in
knock down eﬃciency was observed using the 30 end
shortened sense construct and the LNA-modiﬁed
sisiRNA11+11 design (data not shown). To test if a similar
eﬀect applies to other types of chemical modiﬁcations that
do not increase siRNA thermodynamic stability, we tested
three designs containing either additional single
N20-adamantyl (AS4 and AS5, Table 1) (synthesis will be
described elsewhere) or N20-pyren-1-yl 20-amino-LNA-T
(26) (AS6, Table 1) modiﬁcations in the antisense strand
(Table 1, aT and pT, respectively). These types of
modiﬁcations render the siRNA almost non-functional
when paired to SS1 in a standard (LNA-modiﬁed)
siRNA design (Figure 6B, columns 4, 6 and 8).
However, in the context of the sisiRNA design, both
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Figure 5. The sisiRNA design increases the speciﬁcity of gene silencing.
The knockdown activity of the two strands was assessed by measuring
luciferase expression from reporter constructs containing either the
target sequence for the sense or antisense strand of the EGFP speciﬁc
duplex (light and dark gray bars, respectively). The reporter constructs
are drawn above (not to scale) and the siRNA constructs are indicated
schematically below. The values are averaged over three completely
independent experiments. The luciferase values of each experiment
are normalized to make the sums of the luciferase activities in each
of the experiments equal. For each reporter construct, the ﬁreﬂy
luciferase (Fluc)/renilla luciferase (Rluc) ratio was normalized to
mismatch controls.
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Figure 6. The sisiRNA design supports the silencing eﬀects of chemically modiﬁed antisense strands. (A) Molecular structure of
N20-adamantylmethylcarbonyl 20-amino-LNA-Thymine and N20-pyren-1-ylmethyl 20-amino-LNA-thymine. (B) Analyzing the eﬀect of the sisiRNA
design on the silencing eﬃciency of heavily modiﬁed antisense strands. The mean ﬂuorescence of approximately 50 000 cells was measured by ﬂow
cytometry. The siRNA mismatch represents a siRNA that contains four mismatches to the EGFP target (Table 1). (C) The knockdown activity of
the two siRNA duplex strands was assessed by measuring luciferase expression from reporter constructs containing either the target sequence for the
sense or antisense strand of the EGFP speciﬁc duplex (light and dark gray bars, respectively). The reporter constructs are drawn above (not to scale).
The experiment was performed in triplicate and for each reporter construct the ﬁreﬂy luciferase (Fluc)/renilla luciferase (Rluc) ratio was normalized
to mismatch controls.
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40–60% knock down of EGFP expression (Figure 6,
columns 5, 7 and 9). Hence, the sisiRNA design can
accommodate a wide variety of bulky chemical modiﬁca-
tions that otherwise are incompatible with the activity of
standard duplex siRNA.
To further characterize the mechanism for the relaxed
stringency of antisense strand modiﬁcation, we investi-
gated the incorporation of the sense strand (SS1) into
RISC in lightly modiﬁed antisense siRNA (AS1+SS1) as
compared to the siRNAs with heavily modiﬁed antisense
(AS2+SS1, AS4+SS1, AS5+SS1, AS6+SS1). The
LNA-modiﬁed siRNA (AS1+SS1) caused an  60%
reduction of reporter levels from the sense target
(Figure 6C, column 2), conﬁrming that the sense strand
is indeed incorporated into activated RISC and active.
In contrast, the function of the sense strand was virtually
lost when it was paired to highly modiﬁed antisense
strands (AS2, SS1; AS4, SS1; AS5, SS1; AS6, SS1)
(Figure 6C, columns 6, 10, 14 and 18). Hence, the poor
silencing by the heavily modiﬁed antisense strands (AS2,
AS4, AS5 and AS6) is not simply be due to a shifted
strand selection (towards SS1) during RISC activation.
Instead, heavy modiﬁcation of siRNA duplexes in the
antisense strand seems to abrogate its function at steps
prior to RISC activation. The sisiRNA design, however,
seems to partly rescue such defects thereby allowing
heavily modiﬁed antisense strand to be eﬃciently loaded
into activated RISC. To ensure that the knock down
eﬀects obtained using siRNA with lightly and heavy
modiﬁed sisiRNA or siRNA are speciﬁc, we synthe-
sized the equivalent set of LNA-modiﬁed siRNA
and sisiRNA containing ﬁve mismatched positions
(SS8+AS9, SS8+AS10 and 50SS8+30SS8+AS9,
50SS8+30SS8+AS10, respectively; Table 1) and tested
them in the luciferase reporter assay (Supplementary
Figure 1). The results conﬁrmed the increased potency
of heavily modiﬁed antisense strands when situated in a
sisiRNA design and showed that the knock down was
speciﬁc to the wild type EGFP target sequence.
DISCUSSION
In this study, we have developed a radical new siRNA
design composed of an intact antisense strand comple-
mented with two shorter 10–12nt sense strands. We show
that this three-stranded construct is fully functional and
that it has several advantages over the standard 21nt
duplex siRNA designs. (i) The LNA-modiﬁed sisiRNAs
have similar high potency as compared to standard
siRNAs in cell culture, yet has greatly enhanced stability
in serum which is expectably important for in vivo
applications. (ii) The segmented nature of the passenger
strand completely alleviates its contribution to unwar-
ranted gene knock down thereby greatly increasing
targeting speciﬁcity and expectably reducing oﬀ-target
eﬀects. (iii) The sisiRNA design has the ability to rescue
the function of chemically modiﬁed antisense strands that
are non-functional within the context of a standard
siRNA duplex thereby allowing more chemical
modiﬁcation to be incorporated into the antisense
strand. (iv) The sisiRNA design has six terminal ends
compared to four in normal siRNA which can conveni-
ently be used for tethering functional chemical groups to
enhance, e.g. cellular delivery. For instance, it is possible
to tether bulky groups like cholesterol to the 50 end of the
downstream sense strand without loosing activity
(M.B.L., J.K., J.W., unpublished data). (v) As the yield
of synthesis is usually higher for shorter RNA strands, the
cost of large-scale synthesis in connection with therapeutic
application may be reduced using a sisiRNA design.
An important feature of the sisiRNA design is the
ability to completely eliminate the contribution of
the segmented strand to gene silencing while leaving the
RNAi activity of the opposing strand intact (Figure 5).
The resultant increase in gene silencing speciﬁcity can be
expected to reduce the genome-wide oﬀ-targets eﬀects
from the sense strand that has been observed for other
investigated siRNAs (10). Furthermore, as strand selec-
tion is primarily determined by the thermodynamic
asymmetry of siRNA duplex ends, highly eﬃcient
siRNA may be diﬃcult to design if the target sequence
is restricted to a thermodynamically unfavorable region,
e.g. when the intension is to target single nucleotide
mutation or junctions between fused genes. In these
instances, the sisiRNA design will ensure that only the
unsegmented strand can contribute to gene silencing
irrespectively of the thermodynamic proﬁle of the
sisiRNA duplex and will thereby eliminate the signiﬁcant
unwarranted silencing conferred by the thermodynami-
cally favored opposing strand.
Leuchner et al. (8) have previously demonstrated that
pre-cleaved siRNA, similar to our unmodiﬁed sisiRNA, is
capable of RISC loading and target cleavage in a cell
extract. However, we ﬁnd that sisiRNAs without LNA
residues are non-functional in a cellular context, even if 20
OMe modiﬁed residues are introduced in the short sense
strands (data not shown). Based on our stability assays
(Figure 3B), the most likely explanation is that the
unmodiﬁed strands in sisiRNA are dissociating and
degraded in vivo and that only the signiﬁcant increase in
Tm, provided by the LNA residues, renders the duplex
suﬃciently stable under these conditions.
An interesting observation is that sisiRNA function
does not rely strictly on exact structural mimicry of an
intermediate Ago2-cleavage product as the strand nick can
be moved 1–2nt without major loss of silencing eﬃciency
(Figure 4A, data not shown). In particular, the sisiRNA
design mimicking the ‘natural’ Ago2-cleavage product
(sisiRNA9+13) seems less eﬃcient than when moving the
nick 1 and 2nt towards the 30 end of the sense strand
(sisiRNA10+12 and sisiRNA11+11). Based on in vitro data
from Leuchner et al. (8) these constructs are most likely
cleaved by Ago2, liberating one or two nucleotides,
respectively. It is therefore possible that allowing a
‘natural’ Ago2-cleavage event in the sisiRNA10+12 and
sisiRNA11+11 designs may further help RISC activation
by facilitating subsequent steps such as, e.g. sense strand
elimination. Hence, we believe that the sisiRNA10+12
design introduces novel improvements in siRNAs function
Nucleic Acids Research, 2007, Vol. 35, No. 17 5895beyond those oﬀered by the structural mimicry of natural
intermediates in the RNAi pathway.
We and others have observed that extensive chemical
modiﬁcations in the antisense strand of siRNAs generally
are incompatible with their function in gene silencing
(Figure 6, data not shown)(24). Yet, the speciﬁc steps
in the RNAi pathway, which are incompatible with
extensive siRNA modiﬁcation, are only poorly deﬁned.
Interestingly, the sisiRNA design can signiﬁcantly enhance
the eﬃciency of heavily modiﬁed antisense strands. We
demonstrate here that the inability of extensively LNA-,
LNA/adamantyl- and LNA/pyrenyl-modiﬁed antisense
strands to support RISC activity can be partially rescued
by the sisiRNA-design, whereas both strands of similarly
modiﬁed ordinary siRNAs are non-functional (Figure 6).
This shows that heavy modiﬁcation of an antisense strand
abrogates the function of both sense and antisense strands
that are individually functional within the context of
activated RISC (Figure 6B and C). This suggests that
extensive modiﬁcation of antisense strands may lead to
impairments prior to RISC activation, e.g. siRNA
recruitment by the RLC or structural rearrangements
within pre-RISC. It may be speculated that the segmented
sense strand in the sisiRNA design facilitates the
preferential loading of the intact opposing antisense
strand into activated RISC and thereby enhance their
silencing potential. However, no increase in silencing by
the unsegmented strand in neither AS1+50SS1+30SS1
nor 50AS2+30AS2+SS3 designs was observed as com-
pared to AS1+SS1 (Figure 5). In agreement, no
enhancement in silencing by the sisiRNA design as
compared to siRNA was seen in titration assays
(0.01–100 nM) suggesting that strand selection is not
aﬀected (data not shown). Furthermore, the rescue of
silencing by the sisiRNA design seems not to rely on
alteration of the siRNA thermodynamic proﬁle as the
adamantyl and pyrenyl modiﬁcations, if anything, slightly
destabilize siRNA duplexes in contrast to the stabilizing
eﬀect of the LNA-residues (J.W., unpublished data).
Instead, heavily modiﬁed siRNAs may be too inﬂexible
for structural rearrangements within pre-RISC during
RISC loading or activation. The central strand nick in the
sisiRNA design may provide more structural ﬂexibility to
the sisiRNA duplex allowing it to better position itself
during RISC activation.
The possibility to incorporate more extensive chemical
modiﬁcations into the sisiRNA design as compared to
standard siRNAs may have beneﬁcial properties for steps
both upstream and downstream of RISC activation in the
RNAi pathway. Introducing lipophilic groups like ada-
mantyl and pyrenyl may increase cellular uptake of
siRNA duplexes and unnatural modiﬁcations in general
will increase siRNA stability in intra- and extracellular
compartments. Furthermore, modiﬁcations in the seed
region (nucleotides 2–8 of the antisense strand) may prove
essential to minimize inherent gene oﬀ-target eﬀects by
siRNAs as it has been previously been demonstrated for
position 2 in the antisense strand (14). Finally, it is
possible that increased numbers of LNA residues in the
antisense strand may improve the target speciﬁcity and
aﬃnity.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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